FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Parker Laboratories Helix Tri-Active Therapy Cream Recall

Helix Tri-Active Therapy Cream (Camphor 3

Parker Laboratories, Inc. · Fairfield, NJ

Risk level
Class II
Reported by FDA
Aug 30, 2023
Recall ID
D-1091-2023
Check your lot numberHow we source this data

Summary

Parker Laboratories recalled Helix Tri-Active Therapy Cream starting Aug 2, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1091-2023 on Aug 30, 2023. Reason: CGMP Deviations. Status: Terminated.

Why it was recalled

CGMP Deviations

Product description

Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004

Lot numbers, UPCs & expiration codes

Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023

Where it was sold

Nationwide within the United States, Singapore, Korea and Hong Kong

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1091-2023
Classification
Class II
Status
Terminated
Recall initiated
Aug 2, 2023
FDA report date
Aug 30, 2023
Quantity
8
Recall type
Voluntary: Firm initiated
Recalling firm
Parker Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1091-2023, exactly as published.

Show all FDA fields
City
Fairfield
State
NJ
Status
Terminated
Country
United States
Event ID
92786
Address
286 Eldridge Rd
Code information
Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023
Postal code
07004-2509
Report date
Aug 30, 2023
Product type
Drugs
Recall number
D-1091-2023
Classification
Class II
Recalling firm
Parker Laboratories, Inc.
Product quantity
8
Termination date
Jun 3, 2024
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004
Distribution pattern
Nationwide within the United States, Singapore, Korea and Hong Kong
Recall initiation date
Aug 2, 2023
Initial firm notification
E-Mail
Center classification date
Aug 18, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1091-2023, published Aug 30, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls